Mohamed Badawi, PhD

Clinical Pharmacology
AbbVie Inc.

Poster(s):

• P-229: Exposure-Response Analysis of Venetoclax in Combination with Carfilzomib and Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Patients
  Thursday, September 28, 2023

  12:30 PM – 1:30 PM EEST